Cagatay M. CULCUOGLU

Co-founder & COO/CTO. Healthcare, Financial Services, Media Executive. Entrepreneur & Investor. #AI #Management #Strategy #Marketing

[Cagatay M. CULCUOGLU @Culcuoglu]

Happy new year. Welcome 2024…

[Cagatay M. CULCUOGLU @Culcuoglu]

@TUSIAD Great speakers and event. Familiar faces, looking forward to hearing more about high tech in #Turkiye and digitalisation

[Cagatay M. CULCUOGLU @Culcuoglu]

@endeavor_turkey @Swipeline_tr @ColendiApp @Commencis @figopara @iyzico @alo_tech Great event and speakers at @endeavor_turkey Scaleup Summit.

[Cagatay M. CULCUOGLU @Culcuoglu]

It's been a non-stop summer with the fun of work and lively kids at home 🏡 and sometimes at work😀 Massive Bio. Kudos to our remarkable global team, who are not just keeping the wheels turning but continually innovating and are proud to invest in technology to introduce innovation to benefit cancer patients. Our co-founders gathered in the vibrant city of #istanbul, celebrating 2023's successes and mapping out an even brighter road ahead for 2024 🗺️A visit from one of our esteemed investors DEG from #Germany at our office was exciting. Stay tuned; we have more interesting updates on the horizon.

[Massive Bio @MassiveBio]

Massive Bio's CEO Selin Kurnaz recently made a captivating appearance on Demirören Media, featuring prominent TV channels such as CNN Türk, Kanal D, Euro D, and TEVE 2.

In this exclusive interview, Selin Kurnaz shared valuable insights on the crucial role of clinical trials and the remarkable impact of AI technology in revolutionizing cancer treatment.
As the forefront provider of cancer clinical trial services globally, Massive Bio continues to pave the way for innovative solutions.

Please click to watch:
https://t.co/UpRNYBs8dQ

#MassiveBio #ClinicalTrials #AITechnology #CancerCare

[Massive Bio @MassiveBio]

🌟 We're thrilled to announce that our CEO and Co-Founder, Selin Kurnaz, will be attending ASCO 2023 - the premier event for oncology professionals to discuss the latest advancements in cancer research and treatment.
📅: June 2-6, 2023
📍: McCormick Place, Chicago, IL, USA

[Arturo LoAIza-Bonilla, MD MSEd @DrArturoAI]

#asco23 #AI #gpt4 #clinicaltrials #chatgpt #cancerresearch @MassiveBio

[Massive Bio @MassiveBio]

📣 Join us at the prestigious American Society of Clinical Oncology (ASCO) annual meeting from June 2nd to June 6th!

To learn more: https://t.co/wxxKF6tR8I

#ASCO2023 #RevolutionizingCancerCare #MassiveBio

[Arturo LoAIza-Bonilla, MD MSEd @DrArturoAI]

Thank you @statnews for the shoutout on our first-in-class #ChatGPT powered #chatbots for #clinicaltrials to be showcased at #ASCO23 !! @mattlungrenMD

[Arturo LoAIza-Bonilla, MD MSEd @DrArturoAI]

Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching https://t.co/YIHdVhiCtJ via @clinicalomics

[Massive Bio @MassiveBio]

Massive Bio, the leading AI analytics company specializing in precision oncology, has been chosen by the Precision Cancer Consortium (PCC), a collaboration of renowned global biopharmaceutical companies, to revolutionize clinical trial matching using their innovative AI analytics tools.

Established in 2022, PCC comprises prestigious names like AstraZeneca, Bayer, Eli Lilly & Company, GSK, Johnson & Johnson/Janssen, Novartis, and Roche, all sharing a common goal of providing comprehensive testing for cancer patients worldwide. 🌍

Through this groundbreaking partnership, Massive Bio will integrate PCC member clinical trial protocols and patient inclusion/exclusion criteria into their cutting-edge machine learning matching algorithms within the SYNERGY-AI platform. Leveraging Massive Bio's Deep Learning Clinical Trial Matching System (DLCTMS), this collaboration aims to enhance the quality and efficiency of matching patients to trials across various sponsor programs. 🤝

The result? Improved patient access to targeted Next Generation Sequencing (NGS) testing and personalized interventions. By optimizing the clinical trial matching process, this collaboration will unlock new opportunities for cancer patients and empower them with tailored treatment options. 🎯

We are thrilled to be part of this groundbreaking effort to advance precision oncology and provide hope for millions of patients. Stay tuned for more updates on this game-changing partnership! 🚀

Read more : https://t.co/W4PLB4mKxW

#MassiveBio #PrecisionOncology #ClinicalTrialMatching #AIAnalytics #PrecisionCancerConsortium #Innovation #PersonalizedMedicine

[Arturo LoAIza-Bonilla, MD MSEd @DrArturoAI]

📢Historic news! @MassiveBio partners with @PCCconsortium, leveraging #AI to revolutionize clinical trial matching globally. Pioneering precision oncology to bring the right treatment to every cancer patient. ��🌍 #ASCO23 #MassiveBioPCC #PrecisionMedicine #NextGenOncology

[Melinda B. Chu @MelindaBChu1]

@DrBonillaOnc @MassiveBio @skurnaz Great sunset pic! 🌅📸

[Arturo LoAIza-Bonilla, MD MSEd @DrArturoAI]

Great times and views at the Navy Pier after such a productive day at #ASCO23 @MassiveBio @skurnaz

[Massive Bio @MassiveBio]

@PCCconsortium @DrBonillaOnc @skurnaz @Culcuoglu

[Arturo LoAIza-Bonilla, MD MSEd @DrArturoAI]

@OxlerCeo @statnews @mattlungrenMD @MassiveBio @skurnaz @Culcuoglu 🎯 yes it is all about real use cases that can help us advance the field for good 👍

[Arturo LoAIza-Bonilla, MD MSEd @DrArturoAI]

@GraceCordovano @manjuggm @statnews @mattlungrenMD @MassiveBio @skurnaz @Culcuoglu https://t.co/3oDUBhBTBp

[Massive Bio @MassiveBio]

Big news N°3! 📣 @MassiveBio and @OncologyInst (TOI) team up🤝to transform cancer care and AI-enabled research. With an extensive nationwide network and AI-powered technology, they're set to revolutionize oncology data analysis💻, connecting patients to life-saving treatments and groundbreaking clinical trials. A game-changer for cancer patients everywhere. #PrecisionMedicine #AIforHealth #ASCO23

https://t.co/oEtKHZoi8a

[Massive Bio @MassiveBio]

Introducing @skurnaz and @DrBonillaOnc, co-founders of @MassiveBio with @Culcuoglu, at the #ASCO23 Annual Meeting currently underway in Chicago. Advocating for oncologic patients' access to clinical trials using AI-powered technology.
Think further, Think @MassiveBio.
#AIforHealth #ClinicalTrials #DrArturoAI #Oncology

[Massive Bio @MassiveBio]

📌Last Chance! Get a reminder for "How AI is Driving Personalized Cancer Treatment"

👉: https://t.co/sHc7ltKgNS
🗓️: March 28th 2:00 pm ET

RSVP to learn more about AI's new role in cancer treatment and get the chance to ask your questions during the live Q&A!